Exploring the characteristics of Lower urinary tract dysfunctions in the people with Parkinson disease

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003972

Enrollment

Unknown

Registered

2013-12-09

Start date

2014-01-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

First:M receptor antagonist

Second:Placebo

Eligibility

Sex/Gender

All

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to the 2010 edition of Parkinson's disease diagnosis and treatment guidelines, conforms to the diagnosis of Parkinson's disease; 2. Parkinson's patients with lower urinary tract symptoms, and IPSS > 7.19; 3. The patient cooperate to test.

Exclusion criteria

Exclusion criteria: 1. With hemorrhagic disease, cerebrovascular disease, brain tumor, spinal cord disease, diabetes, urinary stones, related operation, etc.; 2. The disease is severe or the patient can not cooperate to test; 3. The urinary tract infection.

Design outcomes

Primary

Measure	Time frame
urinary peak flow measurement;residual urine;Pressure of detrusor;	—

Countries

China

Contacts

Public ContactTong-wen Ou

Xuanwu Hospital, Capital Medical University

outongwen@sohu.com+86 010-83198460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026